Injunction orders Lexqi to halt U.S. Sales of wearable health tracker BOSTON–(BUSINESS WIRE)–WHOOP, the human performance company, today announced that the U.S. District Court for the District of Massachusetts has granted a motion by WHOOP for a preliminary injunction against Shenzhen Lexqi Electronic Technology Co., Ltd. (Lexqi). The injunction, issued in a trade dress infringement … [Read more…]
PARK CITY, Utah & IRVINE, Calif.–(BUSINESS WIRE)–BioSelective Capital Investments and Shayan Enterprises, LLC, a Utah-based risk-capital investment firm, today announced the successful acquisition of BioDuro’s drug product development and manufacturing operations in Irvine, California, resulting in the formation of Forma Life Sciences, Inc. (FORMA), a Delaware corporation established to hold and operate the acquired assets. … [Read more…]
TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–The first patient has been dosed in a first-in-human phase 1/2 trial evaluating DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. DS3790 is a specifically engineered, potential first-in-class CD37 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568). CD37 is a transmembrane protein that plays … [Read more…]
Football legends unite with royalty for HIV awareness at Stade Louis II ZURICH–(BUSINESS WIRE)–When Leonardo Bonucci, Andriy Shevchenko and Clarence Seedorf lined up alongside Formula 1 star Charles Leclerc on January 24, 2026, it wasn’t for a trophy – it was for a cause. LINVO AG proudly sponsored Cirque FC at the sixth annual Fight … [Read more…]
NEW HAVEN, Conn.–(BUSINESS WIRE)–Veradermics, Incorporated (“Veradermics”), (NYSE: MANE) a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological conditions, today announced the pricing of its upsized initial public offering of 15,077,647 shares of its common stock at an initial public offering price of $17.00 per share. All of the … [Read more…]
CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its fourth quarter and full year 2025 financial results before the opening of the financial markets on Tuesday, February 24, 2026. Management will host a teleconference … [Read more…]
Q3’26 Revenue Increased 26% to $83.9 Million Q3’26 Service Revenue Increased 29% to $53.7 Million Q3’26 Distribution Revenue Grew 20% to $30.2 Million on Increased Demand for Rentals Q3 ’26 Gross Margin Expanded 60 Basis Points to 30.1% Management Reaffirms Fiscal 2026 Service Revenue Expectations Management to Host Conference Call Today at 4:30 p.m. Eastern … [Read more…]
FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–In a notice published earlier today, the Florida Department of Health (DOH) retreated on its decision to make cuts to the State’s AIDS drug program, which provides life-saving medications and health insurance support to over 30,000 Floridians living with HIV/AIDS. Alleging that an undocumented $120 million budget shortfall necessitated the cuts, the … [Read more…]
BIRMINGHAM, Ala.–(BUSINESS WIRE)–#biotech–Southern Research and London-based Pathogenus Consulting have signed a three-year partnership that will allow both organizations to capitalize on growing research opportunities around the world. “We’ve seen clear momentum in our work with partners outside the United States, especially with Japan and European pharmaceutical companies, and the opportunity to broaden that footprint is … [Read more…]
Seasoned drug discovery leader will join Valo to further advance human-centric, AI-enabled drug discovery LEXINGTON, Mass.–(BUSINESS WIRE)–#DrugDiscovery—Valo Health, Inc. (“Valo”), a company pioneering the use of human data and AI to accelerate drug discovery and development, today announced the appointment of Karin Conde-Knape, Ph.D., as Chief Scientific Officer (CSO). Dr. Conde-Knape brings more than two … [Read more…]
